Instil Bio Inc (TIL)
26.85
-0.42
(-1.54%)
USD |
NASDAQ |
Nov 05, 14:53
Instil Bio Research and Development Expense (Annual): 39.60M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 39.60M |
| December 31, 2022 | 141.06M |
| December 31, 2021 | 107.25M |
| Date | Value |
|---|---|
| December 31, 2020 | 19.40M |
| December 31, 2019 | 4.027M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
4.027M
Minimum
2019
141.06M
Maximum
2022
62.27M
Average
39.60M
Median
2023
Research and Development Expense (Annual) Benchmarks
| Merck & Co Inc | 30.53B |
| Elite Pharmaceuticals Inc | 6.883M |
| BioCardia Inc | 7.726M |
| Zevra Therapeutics Inc | 39.81M |
| PetIQ Inc | -- |